AVITA Medical (RCEL) Other financing activities (2021)
AVITA Medical (RCEL) reported Other financing activities of $5.1 million for Q3 2021, little changed quarter-over-quarter from $5.1 million in Q1 2021.
AVITA Medical (RCEL) Other financing activities (2021) Analysis & Trends
AVITA Medical has reported Other financing activities for 1 years, with the latest figure at $5.1 million in Q3 2021.
- For the quarter ending Q3 2021, Other financing activities changed N/A year-over-year to $5.1 million; the trailing twelve-month figure through Sep 2021 stood at $10.2 million (changed N/A YoY), and the FY2021 full-year result was $5.1 million, up 0.63% from the prior year.
- Other financing activities for Q3 2021 stood at $5.1 million, roughly flat from $5.1 million in the prior quarter.
- The five-year high for Other financing activities was $5.1 million in Q1 2021, with the low at $5.1 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | AVITA Medical | 109.91 Mn | 91.73 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 5.11 Mn |
| Sep 30, 2021 | 5.11 Mn |
| Mar 31, 2021 | 5.11 Mn |
| Mar 31, 2021 | 5.11 Mn |